Latest Articles

All Latest Articles

149398 Articles

Steven M. Peters | Mar 23, 2018 at 8:31 PM EDT

50 Most Popular Romance Movies of All Time

There are few emotions that film watchers find more irresistible on the silver screen than love. Each year, hundreds of…

Chris Lange | Mar 23, 2018 at 4:08 PM EDT

Friday’s Biggest Winners and Losers in the S&P 500

Friday was again an absolute disaster for the broad U.S. markets. There didn’t seem to be anything positive about Friday,…

Paul Ausick | Mar 23, 2018 at 4:04 PM EDT

General Electric, CVS Health Slip into Friday’s 52-Week Low Club

General Electric, Forest City Realty Trust, Office Depot, and CVS Health all posted new 52-week lows Friday.

Paul Ausick | Mar 23, 2018 at 4:01 PM EDT

DowDuPont, 3M Sink the Dow Friday

DowDuPont, Goldman Sachs, 3M Company, and Pfizer pushed the Dow lower again Friday.

Sam Stebbins | Mar 23, 2018 at 3:54 PM EDT

Industries With the Best (and Worst) Benefits

U.S. unemployment remains at its lowest point in over a decade. A healthy economy in general spells good things for…

Paul Ausick | Mar 23, 2018 at 1:35 PM EDT

US Oil Rig Count Adds 4 as Crude Price Continues to Climb

The U.S. land rig count rose by five this week, according to the latest report from Baker Hughes. Of that…

Paul Ausick | Mar 23, 2018 at 12:30 PM EDT

Will Losing More Money Make MoviePass Profitable?

Theater subscription service MoviePass has launched a limited time offer for new annual subscribers of $6.95 a month. The last…

Chris Lange | Mar 23, 2018 at 12:20 PM EDT

Dropbox Enters the Market With a Bang (UPDATED)

Dropbox entered the market with a bang on Friday, with shares opening well above their announced pricing.

Chris Lange | Mar 23, 2018 at 12:15 PM EDT

Why Analysts Are Chasing Nike Even Higher

After Nike reported fiscal third-quarter results on Thursday, analysts have cheered on this report, hiking their price targets.

Jon C. Ogg | Mar 23, 2018 at 12:05 PM EDT

Why Goldman Sachs Is So Incredibly Bullish on Cisco Systems

Cisco Systems has come back into focus for investors in 2018, and the networking and security giant was actually the…

Chris Lange | Mar 23, 2018 at 11:30 AM EDT

Why Analysts Are Still Bullish on Micron Technology

Micron Technology released fiscal second-quarter financial results on Thursday, and despite a setback with this report, analysts still seem overly…

Paul Ausick | Mar 23, 2018 at 11:15 AM EDT

Airlines Fight for Less Transparency on Fees

After successfully killing a proposed regulation that would have required airlines to disclose all the fees they charge, the industry…

Chris Lange | Mar 23, 2018 at 10:25 AM EDT

Pfizer’s Chantix Study Goes Up in Smoke

Pfizer shares slipped slightly on Friday after the pharma giant announced results from its Chantix/Champix smoking cessation study in adolescents.

Paul Ausick | Mar 23, 2018 at 10:15 AM EDT

Does a Target, Kroger Merger Make Sense?

A report that Target and Kroger were discussing a possible merger was followed quickly by another denying that such discussions…

Chris Lange | Mar 23, 2018 at 9:50 AM EDT

Is the FDA Expecting More Problems for Progenics?

Progenics Pharmaceuticals shares took a big step back on Friday after the firm announced that it received an update from…

1 … 4,427 4,428 4,429 4,430 4,431 … 9,960

Latest Articles

All Latest Articles

50 Most Popular Romance Movies of All Time

Friday’s Biggest Winners and Losers in the S&P 500

General Electric, CVS Health Slip into Friday’s 52-Week Low Club

DowDuPont, 3M Sink the Dow Friday

Industries With the Best (and Worst) Benefits

US Oil Rig Count Adds 4 as Crude Price Continues to Climb

Will Losing More Money Make MoviePass Profitable?

Dropbox Enters the Market With a Bang (UPDATED)

Why Analysts Are Chasing Nike Even Higher

Why Goldman Sachs Is So Incredibly Bullish on Cisco Systems

Why Analysts Are Still Bullish on Micron Technology

Airlines Fight for Less Transparency on Fees

Pfizer’s Chantix Study Goes Up in Smoke

Does a Target, Kroger Merger Make Sense?

Is the FDA Expecting More Problems for Progenics?

History Says This Unstoppable Dow Juggernaut Is a No-Brainer Buy Right Now

Lucid Stock Is Deeply Oversold and We See 45% Gains Ahead

The $1,847 Monthly Survivor Benefit Most Widows Leave on the Table by Filing at the Wrong Age

The $1,847 Monthly Survivor Benefit Most Widows Leave on the Table by Filing at the Wrong Age

The West's Home Prices Just Fell 1.4% While the Rest of America Climbed. Here's Why.

History Says This Unstoppable Dow Juggernaut Is a No-Brainer Buy Right Now

Lucid Stock Is Deeply Oversold and We See 45% Gains Ahead

Latest Articles

All Latest Articles

50 Most Popular Romance Movies of All Time

Friday’s Biggest Winners and Losers in the S&P 500

General Electric, CVS Health Slip into Friday’s 52-Week Low Club

DowDuPont, 3M Sink the Dow Friday

Industries With the Best (and Worst) Benefits

US Oil Rig Count Adds 4 as Crude Price Continues to Climb

Will Losing More Money Make MoviePass Profitable?

Dropbox Enters the Market With a Bang (UPDATED)

Why Analysts Are Chasing Nike Even Higher

Why Goldman Sachs Is So Incredibly Bullish on Cisco Systems

Why Analysts Are Still Bullish on Micron Technology

Airlines Fight for Less Transparency on Fees

Pfizer’s Chantix Study Goes Up in Smoke

Does a Target, Kroger Merger Make Sense?

Is the FDA Expecting More Problems for Progenics?

History Says This Unstoppable Dow Juggernaut Is a No-Brainer Buy Right Now

Lucid Stock Is Deeply Oversold and We See 45% Gains Ahead

The $1,847 Monthly Survivor Benefit Most Widows Leave on the Table by Filing at the Wrong Age

Featured Reads

The $1,847 Monthly Survivor Benefit Most Widows Leave on the Table by Filing at the Wrong Age

The West's Home Prices Just Fell 1.4% While the Rest of America Climbed. Here's Why.